![PDF) TaffiX® nasal powder spray forms an effective barrier against infectious new variants of SARS-CoV-2 (COVID-19) PDF) TaffiX® nasal powder spray forms an effective barrier against infectious new variants of SARS-CoV-2 (COVID-19)](https://i1.rgstatic.net/publication/350913017_TaffiXR_nasal_powder_spray_forms_an_effective_barrier_against_infectious_new_variants_of_SARS-CoV-2_COVID-19/links/6079d28d2fb9097c0ceca0c8/largepreview.png)
PDF) TaffiX® nasal powder spray forms an effective barrier against infectious new variants of SARS-CoV-2 (COVID-19)
![Covid Spain: Regulators BAN £51 Taffix nasal spray that studies show may cut infection risk | Daily Mail Online Covid Spain: Regulators BAN £51 Taffix nasal spray that studies show may cut infection risk | Daily Mail Online](https://i.dailymail.co.uk/1s/2021/03/16/17/40548952-0-image-a-3_1615914265002.jpg)
Covid Spain: Regulators BAN £51 Taffix nasal spray that studies show may cut infection risk | Daily Mail Online
![Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel](https://static.timesofisrael.com/www/uploads/2021/02/taffix-640x400.jpg)
Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering | The Times of Israel
![Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection](https://mma.prnewswire.com/media/1485582/Nasus_Pharma_Logo.jpg?p=twitter)
Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection
Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly end
![Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS‐COV‐2 - Moakes - 2021 - Advanced Materials - Wiley Online Library Formulation of a Composite Nasal Spray Enabling Enhanced Surface Coverage and Prophylaxis of SARS‐COV‐2 - Moakes - 2021 - Advanced Materials - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b6c9a965-2682-4fb8-a38f-418de4505585/adma202008304-fig-0003-m.jpg)